Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 16:19:11795549251335172.
doi: 10.1177/11795549251335172. eCollection 2025.

Distribution of PAX1 and ZNF582 Hypermethylation in the Oral Exfoliated Cells of Oral Squamous Cell Carcinoma

Affiliations

Distribution of PAX1 and ZNF582 Hypermethylation in the Oral Exfoliated Cells of Oral Squamous Cell Carcinoma

Ya-Qing Mao et al. Clin Med Insights Oncol. .

Abstract

Background: The DNA methylation statuses of PAX1 and ZNF582 show great promise as biomarkers for the detection of oral squamous cell carcinoma (OSCC). This study aims to investigate the distribution of PAX1 or ZNF582 methylation in the exfoliated oral epithelial cells (OECs) of OSCC.

Methods: Methylation data from 528 tumors and 50 adjacent nontumor tissues were acquired from The Cancer Genome Atlas and analyzed using UALCAN database. Sixty-one OSCC cases from Peking University School and Hospital of Stomatology were included in this study and the exfoliated OECs collected by oral swabs were collected from the cancerous lesion (CL), adjacent normal (AN), and contralateral normal (CN) sites. The methylation levels of these 2 genes in different sites were evaluated.

Results: PAX1 and ZNF582 were both hypermethylated in OSCC compared with nontumor sites but showed different methylation patterns within the oral environment. Generally, a CL-centric methylation pattern of PAX1 where methylation levels decrease gradually from CL through AN to CN was observed, suggesting a field cancerization effect. ZNF582 methylation levels are significantly higher at lesion sites compared with normal sites, but no significant difference is observed between AN and CN. Coexistence of ZNF582 methylation in CL and AN or CN sites was also observed in some patients with OSCC. Furthermore, ZNF582 methylation was more sensitive among patients with OSCC.

Conclusions: DNA methylation detection of PAX1 and ZNF582 in the exfoliated OECs is helpful for OSCC diagnosis. Hypermethylated PAX1 and ZNF582 show different methylation patterns in the oral cavity of patients with OSCC.

Keywords: DNA methylation; Oral squamous cell carcinoma; PAX1; ZNF582; field cancerization; oral swab; tumor suppressor gene.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Collect oral exfoliated cell samples from the cancerous lesion (A), cancer-adjacent normal area (B), contralateral normal area (C) sites, and break off the sampling brush head into a storage tube (D).
Figure 2.
Figure 2.
Use the UALCAN database to analyze the differences in PAX1 expression levels (A) in 520 HNSCC tumor tissues and 44 normal tissues and promoter methylation levels (B) in 528 HNSCC cancer tissues and 50 normal tissues between HNSCC and normal tissues sourced from The Cancer Genome Atlas. Compare the grade of differentiation (C), nodal metastasis status (D), TNM stage (E), and smoking status (F) with the PAX1 promoter methylation levels.
Figure 3.
Figure 3.
Use the UALCAN database to analyze the differences in ZNF582 expression levels (A) in 520 HNSCC tumor tissues and 44 normal tissues and promoter methylation levels (B) in 528 HNSCC cancer tissues and 50 normal tissues between HNSCC and normal tissues sourced from The Cancer Genome Atlas. Compare the grade of differentiation (C), nodal metastasis status (D), TNM stage (E), and smoking status (F) with the ZNF582 promoter methylation levels.
Figure 4.
Figure 4.
The M-indexes (A) and coexistence (B) of PAX1 and ZNF582 at the cancerous lesion site (CL), cancer-adjacent normal site (AN), and contralateral normal site (CN).
Figure 5.
Figure 5.
Gender (A), age (B), smoking status (C), alcohol consumption (D), and multiple risk factors (E) effects on the coexistence of DNA methylation at the cancerous lesion site (CL), cancer-adjacent normal site (AN), and contralateral normal site (CN).
Figure 6.
Figure 6.
The effect of tumor size (A), lymph node metastasis (B), tumor stage (C), differentiation (D), and bone invasion (E) on the coexistence of DNA methylation at the cancerous lesion site (CL), cancer-adjacent normal site (AN), and contralateral normal site (CN).

Similar articles

References

    1. Muller S, Tilakaratne WM. Update from the 5th edition of the World Health organization classification of head and neck tumors: tumours of the oral cavity and mobile tongue. Head Neck Pathol. 2022;16:54-62. doi:10.1007/s12105-021-01402-9 - DOI - PMC - PubMed
    1. Bray F, Laversanne M, Sung H, et al.. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-263. doi:10.3322/caac.21834 - DOI - PubMed
    1. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92. doi:10.1038/s41572-020-00224-3 - DOI - PMC - PubMed
    1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): head and neck cancers, 2025.
    1. Chamoli A, Gosavi AS, Shirwadkar UP, et al.. Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451. doi:10.1016/j.oraloncology.2021.105451 - DOI - PubMed

LinkOut - more resources